Feedback / Questions
AB-16B5 - Alethia BioTherap
http://www.globenewswire.com/news-release/2020/05/21/2036916/0/fr/Alethia-Bioth%C3%A9rapeutiques-annonce-l-autorisation-par-la-FDA-d-initier-une-%C3%A9tude-de-phase-2-pour-son-inhibiteur-de-la-TEM-l-AB-16B5.html
May 21, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next